Welch Allyn to sell Cardionetics' monitor in UK:
This article was originally published in Clinica
Executive Summary
Welch Allyn is to distribute Hampshire, UK-based Cardionetics' C.Net2000+ ambulatory 24-hour ECG monitor in the UK under an exclusive arrangement. Welch Allyn says the product is an excellent fit with its own primary care products, including diagnostic instruments and patient monitoring systems. The product "will enable primary care practices to examine cardiac arrhythmia within the practice environment, thus speeding up diagnosis, reducing unnecessary hospital referrals and facilitating better use of resources," said Steve MacAleese, UK general manager of Welch Allyn.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.